SCHEMBL777741

SCHEMBL777741

CCC(C)OP(C)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL5026575 0.84 ACHE (0.30)
SCHEMBL25787055 0.82 LAP3 (0.46)
SCHEMBL485995 0.82
SCHEMBL497286 0.82 LAP3 (0.39)
SCHEMBL11386365 0.81 METAP1 (0.47)
Hydrochloric Acid SCHEMBL6047705 0.80 SMPD1 (0.42)
SCHEMBL27505457 0.80 SMPD1 (0.42)
SCHEMBL9259903 0.80
SCHEMBL2185946 0.80 LAP3 (0.37)
SCHEMBL777740 0.79 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170175129-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS INC (US) 2017-06-22 US claimed
US-20170136131-A1 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Modema Therapeutics, Inc. (US) 2017-05-18 US claimed
EP-3157572-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP claimed
US-20160304552-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. 2016-10-20 US claimed
EP-3080289-A2 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2016-10-19 EP claimed
WO-2015196130-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO claimed
US-20150307542-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF MODERNATX, INC. 2015-10-29 US claimed
EP-2931319-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2015-10-21 EP claimed
WO-2015089511-A2 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-06-18 WO claimed
WO-2014093924-A1 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2014-06-19 WO claimed
US-20250298333-A1 POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2025-09-25 US disclosed
CN-115449150-B Resin composition and method for producing same 柯尼卡美能达株式会社 2024-10-29 CN disclosed
CN-118834238-A Methyl phosphonite diethyl ester synthesis method 南京华洲药业有限公司 2024-10-25 CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
CN-112930345-B Novel halo- (3- (benzenesulfonyl) prop-1-ene) pyridine derivatives and use thereof 库尔维斯株式会社 2024-09-24 CN disclosed
CN-1328546-A Pyrrolidines as Neuraminidase Inhibitors ABBOTT LAB (US) 2001-12-26 CN disclosed
CN-1326459-A Novel heteroaromatic inhibitors of fructose-1, 6-bisphosphatase METABASIS THERAPEUTICS INC (US) 2001-12-12 CN disclosed
CN-1059528-A The new carbocyclic analogs of some nucleosides MERRELL DOW PHARMA (US) 1992-03-18 CN disclosed
CN-1036578-A NOVEL FLUOROPHOSPHONATE NUCLEOTIDE DERIVATIVES MERRELL DOW PHARMA (US) 1989-10-25 CN disclosed
US-4263431-A ARYL QUATERNARY AMINE PHOSPHONATE DERIVATIVES CIBA-GEIGY CORPORATION (US) 1981-04-21 US disclosed